Early treatment of Campylobacter jejuni enteritis.
The bacteriologic and clinical effects of early antibiotic treatment of Campylobacter jejuni enteritis were studied. Erythromycin rapidly eliminated C. jejuni from stools, whereas trimethoprim-sulfamethoxazole did not. Despite its bacteriologic effectiveness, erythromycin did not reduce the duration or severity of diarrhea, abdominal pain, or other symptoms.
Williams
M D
MD
Department of Medicine, University of Virginia Medical Center, Charlottesville 22908.
Schorling
J B
JB
Barrett
L J
LJ
Dudley
S M
SM
Orgel
I
I
Koch
W C
WC
Shields
D S
DS
Thorson
S M
SM
Lohr
J A
JA
Guerrant
R L
RL
D000328:Adult; D002169:Campylobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D002168:Campylobacter fetus / Q000187:drug effects; D002648:Child; D004338:Drug Combinations / Q000494:pharmacology / Q000627:therapeutic use; D004751:Enteritis / Q000188:drug therapy* / Q000382:microbiology; D004917:Erythromycin / Q000494:pharmacology / Q000627:therapeutic use*; D005243:Feces / Q000382:microbiology; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D013420:Sulfamethoxazole / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors; D014295:Trimethoprim / Q000494:pharmacology / Q000627:therapeutic use*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D004338:Drug Combinations; D004917:Erythromycin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole